The Dow hit an all-time high on Tuesday but there were still many stocks that did not join in the rally. Keep an eye on value and away from these stocks More
-
-
Sponsored By:
-
Sponsored By:
HSP
Recent Articles
9 Pharmaceutical Stocks to Sell Now
This week, the overall grades of nine Pharmaceutical stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell"). More
5 Funds That Will Profit From Mega-Trends
Rather than stock-picking to profit off today's major trends, investors can improve their chances by buying into these mutual funds and ETFs. More
Investors Still Must Pick Generic Drug Companies By Hand
The high-risk generic drug sector still is without an ETF, leaving investors to weed out the pharmaceutical winners and losers for themselves. More
Apple Bombs, Sectors Revolt — Tuesday’s IP Market Recap
Apple records a rare earnings miss after the bell, and Goldman Sachs and IBM misses couldn't hold back financials and techs Tuesday. More
7 Pharma Stocks to Sell, STAT
Pharmaceutical stocks are theoretically recession-proof. Still, not all pharma companies are equal. Here are seven clear losers to toss. More
Shortage of Cancer Drugs Jeopardizes Development of New Treatments
Existing products often are used in new drugs' clinical trials, meaning a cramp in supply can result in delays of even years for new treatments. More
